A carregar...
Dendritic Cell-Induced Th1 and Th17 Cell Differentiation for Cancer Therapy
The success of cellular immunotherapies against cancer requires the generation of activated CD4(+) and CD8(+) T-cells. The type of T-cell response generated (e.g., Th1 or Th2) will determine the efficacy of the therapy, and it is generally assumed that a type-1 response is needed for optimal cancer...
Na minha lista:
| Publicado no: | Vaccines (Basel) |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
MDPI
2013
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4494209/ https://ncbi.nlm.nih.gov/pubmed/26344346 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/vaccines1040527 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|